Integer Complaint Overview
The class action lawsuit asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Integer common stock. The class action is pending in the U.S. District Court for the Southern District of New York. It is captioned West Palm Beach Firefighters’ Pension Fund v. Integer Holdings Corporation, et al., No. 1:25-cv-10251.
If you lost money on your Integer investment, you are encouraged to submit your information using the form on this page. You may also email ross@bfalaw.com or call 212.789.3619.
Why is Integer Being Sued for Securities Fraud?
Integer has been sued for securities fraud following a significant stock drop resulting from potential violations of the federal securities laws. The decline in Integer’s stock price caused significant losses to investors.
Integer designs and manufactures medical devices, specializing in cardiac rhythm management and cardiovascular products, including electrophysiology (“EP”) devices that map the heart’s electrical activity to diagnose and treat arrhythmias. During the relevant period, Integer repeatedly touted its EP sales growth and market position while overstating demand for its EP devices.
In truth, as alleged, demand for and revenue from Integer’s EP products had fallen sharply—directly contradicting the company’s public assurances.
Why did Integer’s Stock Drop?
On October 23, 2025, Integer disclosed that it lowered its 2025 sales guidance to a range between $1.840 billion and $1.854 billion, from a range between $1.850 billion and $1.876 billion, and well below analysts’ estimates. The company also revealed that it expected poor net sales growth of -2% to 2% and organic sales growth of 0% to 4% for 2026. Integer also admitted that two of its EP devices experienced “slower than forecasted” adoption and that it expected the slower demand “to continue into 2026.”
This news caused the price of Integer stock to drop $35.22 per share, or more than 32%, from a closing price of $109.11 per share on October 22, 2025, to $73.89 per share on October 23, 2025.
Integer Holdings Corporation (ITGR) Stock Chart
NYSE online chart showing the Integer Holdings Corporation (ITGR) stock drop following the October 23, 2025 announcement.
What is the Integer Leadership Deadline?
You may ask the Court no later than February 9, 2026, to appoint you as Lead Plaintiff through counsel of your choice.
To be a member of the Class, you need not take any action at this time. The ability to share in any potential future recovery is not dependent on serving as Lead Plaintiff.
How Do I Submit My Information?
If you lost money when Integer common stock dropped in price, you are encouraged to submit your information using the form on this page to speak with an attorney about your rights.
You can also contact:
Ross Shikowitz
ross@bfalaw.com
212.789.3619
All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of the class action lawsuit. The firm will seek court approval for any potential fees and expenses.
Why Bleichmar Fonti & Auld LLP?
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS.
BFA attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.
BFA’s notable successes include a recovery of over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Attorney advertising. Past results do not guarantee future outcomes.
